9 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... summarizes the A1C ... #pharmacology #pharmacotherapy ... #table #comparison
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
#pharmacology #table ... #comparison #dosing ... #insulin #diabetes
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
: Weight-Based Dosing ... Patients without clear ... #TDD #Insulin #dosing ... Weight #Based #pharmacology ... endocrinology #diabetes
Insulin Degludec (Tresiba) vs Insulin Glargine (Lantus, Basaglar, or Toujeo)

Insulin degludec (Tresiba) is an ultra-long acting
do require BID dosing ... CV outcomes and A1c ... Degludec #Glargine #Comparison ... #Pharmacology # ... DEVOTE #Diabetes
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... has a smaller A1c ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes
Pericardial Consistency Comparison on POCUS - Blood, Fat, Pus and Serous

Unclotted blood remains anechoic around clotted
Pericardial Consistency Comparison ... have loculations moving ... Serous effusion ... #Pericardial #Effusion ... Echocardiogram #S4C
GLP-1 Medications: Ozempic vs. Trulicib (semaglutide vs. dulaglutide) 

From my experience, Ozempic and Trulicity are the
significantly better A1c ... additional -0.3% A1c ... only for type 2 diabetes ... #dulaglutide #Pharmacology ... #Diabetes #Comparison
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... have significant A1c ... #semaglutide #Diabetes ... #Pharmacology #
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
hypertension, diabetes ... dose, continuous infusion ... every 3 months during ... cardiology #oncology #pharmacology